Other languages Ningbo Menovo Pharmaceutical Co., Ltd.

Equities

603538

CNE100002Y25

End-of-day quote Shanghai S.E. Other stock markets 06:00:00 2024-07-14 pm EDT			5-day change	1st Jan Change
11.73 ^CNY	-2.25%		-2.49%	-38.65%

Jun. 26	Menovo Pharmaceutical Unit Gets Registration Certificate for Glucosamine Sulfate Capsules	MT
May. 24	China Approves Menovo Pharma's Type 2 Diabetes Drug	MT

Other languages

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Menovo Pharmaceutical Unit Gets Registration Certificate for Glucosamine Sulfate Capsules	Jun. 26
China Approves Menovo Pharma's Type 2 Diabetes Drug	May. 24
Ningbo Menovo Pharmaceutical Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023	Apr. 29
Ningbo Menovo Pharmaceutical Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024	Apr. 29
Menovo Pharma's Unit Gets Nod to Market Clopidogrel Hydrogen Sulfate Tablets	Mar. 06
Menovo Pharma Gets Nod to Market Raw Drug Ingredient for Hypertension Into EU Market; Shares Up 3%	Mar. 04
Ningbo Menovo Pharma Registers Seizure Drug in China	Dec. 05
Ningbo Menovo Pharmaceutical Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2023	23-10-26
Menovo Pharmaceutical Unit's Rosuvastatin Calcium Passes Drug Regulator's Technical Review	23-10-11
Ningbo Menovo Pharma Registers Blood Pressure Drug	23-09-06
Ningbo Menovo Pharmaceutical Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2023	23-08-30
Menovo Pharmaceutical's Unit Gets Nod to Own Olmesartan Medoxomil Tablets	23-07-14
Menovo Pharma Gets European Certification for Diet Drug	23-06-08
Menovo Pharma Gets Registration Certificate for Moxifloxacin Hydrochloride Tablets	23-05-25
Ningbo Menovo Pharmaceutical Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2023	23-04-28
Menovo Pharma Unit's Diet Control Drug Passes Regulator Evaluation	22-12-20
Menovo Pharma's API Obtains European Certificate	22-12-16
Ningbo Menovo Pharmaceutical Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2022	22-10-14
Ningbo Menovo Pharmaceutical Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2022	22-08-15
Ningbo Menovo Pharmaceutical Co., Ltd. completed the acquisition of remaining 49% stake in Xuancheng Menovo Pharmaceutical Co., Ltd. from Ningbo Menovo Ruihe Equity Investment Partnership	22-06-30

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Other languages Ningbo Menovo Pharmaceutical Co., Ltd.

Equities

603538

CNE100002Y25

Other languages

Filters